BioSpace News Archive

Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration

Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie

Rumors of a Revolution buyout come as the industry gears up for one of its biggest trade conferences, where observers expect many such deals to be announced.

January 9, 2026

·

1 min read

·

Tristan Manalac

Layoffs

InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot

Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization in 2023. The therapy failed a late-stage trial in a rare skin disease last year.

January 9, 2026

·

1 min read

·

Tristan Manalac

Handmade signboard with Closed inscription and striped rope hanging on pin on bright red background

Layoffs

Rampart Closes Down Less Than 2 Years After Launch

Rampart Bioscience was working on a platform to deliver gene therapies without the need for viral vectors.

January 9, 2026

·

1 min read

·

Tristan Manalac

Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.

Lung cancer

Roche Spends $570M on Another ADC Agreement With China’s MediLink

Roche first partnered with MediLink in January 2024, likewise for an antibody-drug conjugate for solid tumors.

January 9, 2026

·

1 min read

·

Tristan Manalac

Creative picture image collage banner of guy worker jump from financial charts determined company success.

Earnings

Insmed Jumps on ‘Blowout’ Sales Beat for Bronchiectasis Drug Brinsupri

Insmed’s freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first full quarter of sales.

January 9, 2026

·

1 min read

·

Dan Samorodnitsky

Pictured: San Francisco’s Union Square/iStock, tra

Mergers & acquisitions

At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun

Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.

January 9, 2026

·

4 min read

·

Annalee Armstrong

Press Releases

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

January 9, 2026

·

4 min read

Press Releases

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy